Price T Rowe Associates Inc Ligand Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 13,737 shares of LGND stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,737

Previous 13,591 1.07%

Holding current value

$1.69 Million

Previous $1.15 Million 19.97%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $12,074 - $16,076	146 Added 1.07%	13,737 $1.38 Million
Q2 2024 Aug 14, 2024	BUY	$68.53 - $87.91 $41,049 - $52,658	599 Added 4.61%	13,591 $1.15 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $41,870 - $54,412	610 Added 4.93%	12,992 $951,000
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $42,630 - $62,461	860 Added 7.46%	12,382 $885,000
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $64,981 - $80,227	1,104 Added 10.6%	11,522 $692,000
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $58,057 - $66,240	835 Added 8.71%	10,418 $752,000
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $71,383 - $83,785	1,087 Added 12.79%	9,583 $705,000
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $13,516 - $21,186	219 Added 2.65%	8,496 $568,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $12 - $138,107	1,284 Added 18.36%	8,277 $713,000
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $84,580 - $132,863	-1,135 Reduced 13.96%	6,993 $624,000
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $59,463 - $94,876	626 Added 8.34%	8,128 $914,000
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $158,846 - $206,317	-1,244 Reduced 14.22%	7,502 $1.16 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $63,444 - $89,732	-620 Reduced 6.62%	8,746 $1.22 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $99,353 - $136,807	-879 Reduced 8.58%	9,366 $1.23 Million
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $5.33 Million - $11.6 Million	-53,573 Reduced 83.95%	10,245 $1.56 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $5.14 Million - $6.77 Million	63,818 New	63,818 $6.35 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Ligand Pharmaceuticals Inc Transaction History